Protocol S2212, Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study (NCT TBD)
Details
Age
Adult
Locations
Memorial Hospital Central
Memorial Hospital North
Principal Investigator
Uchenna Njiaju
Study ID
Protocol Number: 23-2438
More information available at ClinicalTrials.gov: NCT05929768
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers